Lou Silverman insider trades
Open-market stock purchases and sales by Lou Silverman, Director at Insight Molecular Diagnostics Inc, from SEC Form 4 filings since Jan 1, 2010.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +175%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jul 1, 2026 | IMDX Insight Molecular Diagnostics Inc | Sold (not open market) | $43.8K |
| Jun 18, 2026 | STAA Staar Surgical Co | Bought (not open market) | — |
| Jun 18, 2026 | STAA Staar Surgical Co | Bought (not open market) | — |
| Jun 11, 2026 | IMDX Insight Molecular Diagnostics Inc | Bought (not open market) | — |
| Jun 1, 2026 | MDRX Veradigm Inc | Bought (not open market) | — |
Companies traded
- IMDX Insight Molecular Diagnostics Inc: other filings, last Jul 1, 2026
- STAA Staar Surgical Co: 1 buy, 3 sales, last Jun 18, 2026
- MDRX Veradigm Inc: other filings, last Jun 1, 2026
- OCX Oncocyte Corp: other filings, last Jul 1, 2024
- CMRO Comarco Inc: other filings, last Oct 27, 2016
- QCOR Questcor Pharmaceuticals Inc: 1 sale, last Aug 14, 2014